Home › NDC Lookup › Labelers › Bamboo Us Bidco Lcc

Bamboo Us Bidco Lcc NDCs and Package Codes

This page lists NDC package records associated with labeler code 83703 (Bamboo Us Bidco Lcc) — including active listings, ingredients, drug names, strengths, dosage forms, package sizes, pricing data when available, and links to each individual NDC page.

Key stats

35
Package NDCs
34
Products
32
Active listings
2
Discontinued
20
Ingredients
0
Therapeutic classes
8
Dosage forms
0
With NADAC pricing

Portfolio

Top ingredients
rituximab-arrx 4
cyclophosphamide 3
choriogonadotropin alfa 2
INFLUENZA A VIRUS A/Victoria/4897/... 2
INFLUENZA A VIRUS A/Georgia/12/202... 2
Hepatitis B Vaccine (Recombinant) 2
zolbetuximab 2
tisotumab vedotin 2
enfortumab vedotin 2
mecasermin 2
By dosage form
INJECTION, SOLUTION 8
INJECTION, POWDER, LYOPHILIZED, FO... 7
INJECTION, SUSPENSION 6
INJECTION, POWDER, FOR SOLUTION 5
INJECTION 4
INJECTION, SOLUTION, CONCENTRATE 2
INJECTION, POWDER, LYOPHILIZED, FO... 1
POWDER, FOR SOLUTION 1

Browse records — 34 products

Drug / product Billing NDC NADAC / unit Status
brentuximab vedotin 50.5 mg/10.5mL POWDER, FOR SOLUTION Bamboo · NDC 83703-0564-81 · 81 VIAL, SINGLE-DOSE in 1 BOX (83703-564-81) / 10.5 mL in 1 VIAL, SINGLE-DOSE 83703-0564-81 — On market View →
Busulfan 6 mg/mL INJECTION Bamboo · NDC 83703-0567-10 · 8 VIAL in 1 PACKAGE (83703-567-10) / 10 mL in 1 VIAL 83703-0567-10 — On market View →
choriogonadotropin alfa 10000 [USP'U]/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Bamboo · NDC 83703-0572-10 · 2 VIAL in 1 BOX (83703-572-10) / 10 mL in 1 VIAL 83703-0572-10 — On market View →
choriogonadotropin alfa 10000 [USP'U]/10mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Bamboo · NDC 83703-0001-89 · 2 VIAL in 1 BOX (83703-001-89) / 10 mL in 1 VIAL 83703-0001-89 — On market View →
CYCLOPHOSPHAMIDE 500 mg/25mL INJECTION, POWDER, FOR SOLUTION Bamboo · NDC 83703-0549-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-549-01) / 25 mL in 1 VIAL, SINGLE-DOSE (83703-549-25) 83703-0549-01 — On market View →
CYCLOPHOSPHAMIDE 1 g/50mL INJECTION, POWDER, FOR SOLUTION Bamboo · NDC 83703-0550-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-550-01) / 50 mL in 1 VIAL, SINGLE-DOSE (83703-550-50) 83703-0550-01 — On market View →
CYCLOPHOSPHAMIDE 2 g/100mL INJECTION, POWDER, FOR SOLUTION Bamboo · NDC 83703-0551-01 · 1 VIAL, SINGLE-DOSE in 1 CARTON (83703-551-01) / 100 mL in 1 VIAL, SINGLE-DOSE (83703-551-10) 83703-0551-01 — On market View →
Datopotamab Deruxtecan 100 mg/mL INJECTION Bamboo · NDC 83703-0530-01 · 273 VIAL in 1 CARTON (83703-530-01) / 1 mL in 1 VIAL 83703-0530-01 — On market View →
enfortumab vedotin 30 mg/3mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Bamboo · NDC 83703-0571-73 · 273 VIAL, SINGLE-DOSE in 1 CARTON (83703-571-73) / 3 mL in 1 VIAL, SINGLE-DOSE 83703-0571-73 — On market View →
enfortumab vedotin 20 mg/2mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Bamboo · NDC 83703-0570-73 · 273 VIAL, SINGLE-DOSE in 1 CARTON (83703-570-73) / 2 mL in 1 VIAL, SINGLE-DOSE 83703-0570-73 — On market View →
Flucelvax INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Bamboo · NDC 83703-0084-03 · 10 SYRINGE, GLASS in 1 CARTON (83703-084-03) / .5 mL in 1 SYRINGE, GLASS (83703-084-04) 83703-0084-03 — Discontinued View →
Flucelvax INFLUENZA A VIRUS A/Georgia/12/2022 CVR-167 (H1N1) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA A VIRUS A/Victoria/800/2024 CVR-289 (H3N2) ANTIGEN (MDCK CELL DERIVED, PROPIOLACTONE INACTIVATED), INFLUENZA B VIRUS B/Singapore/WUH4618/2 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Bamboo · NDC 83703-0088-03 · 10 SYRINGE, GLASS in 1 CARTON (83703-088-03) / .5 mL in 1 SYRINGE, GLASS (83703-088-04) 83703-0088-03 — On market View →
FLUZONE TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Bamboo · NDC 83703-0083-50 · 10 SYRINGE, GLASS in 1 PACKAGE (83703-083-50) / .5 mL in 1 SYRINGE, GLASS (83703-083-88) 83703-0083-50 — Discontinued View →
FLUZONE TRIVALENT NORTHERN HEMISPHERE INFLUENZA A VIRUS A/Victoria/4897/2022 IVR-238 (H1N1) ANTIGEN (FORMALDEHYDE INACTIVATED), INFLUENZA A VIRUS A/Croatia/10136/RV/2023 (H3N2) ANTIGEN (FORMALDEHYDE INACTIVATED), and INFLUENZA B VIRUS B/MICHIGAN/01/2021 ANTIGEN (FORMALDEHYDE INACTIVATED) 15 ug/.5mL; 15 ug/.5mL INJECTION, SUSPENSION Bamboo · NDC 83703-0087-50 · 10 SYRINGE, GLASS in 1 PACKAGE (83703-087-50) / .5 mL in 1 SYRINGE, GLASS (83703-087-88) 83703-0087-50 — On market View →
HEPLISAV-B Hepatitis B Vaccine (Recombinant) Adjuvanted 20 ug/.5mL INJECTION, SOLUTION Bamboo · NDC 83703-0048-05 · 5 SYRINGE in 1 CARTON (83703-048-05) / .5 mL in 1 SYRINGE (83703-048-01) 83703-0048-05 — On market View →
lurbinectedin .5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Bamboo · NDC 83703-0583-26 · 126 VIAL in 1 CARTON (83703-583-26) / 8 mL in 1 VIAL 83703-0583-26 — On market View →
mecasermin 40 mg/4mL INJECTION, SOLUTION Bamboo · NDC 83703-0568-73 · 1 VIAL, MULTI-DOSE in 1 CARTON (83703-568-73) / 4 mL in 1 VIAL, MULTI-DOSE 83703-0568-73 — On market View →
mecasermin 40 mg/4mL INJECTION, SOLUTION Bamboo · NDC 83703-0569-73 · 1 VIAL, MULTI-DOSE in 1 CARTON (83703-569-73) / 4 mL in 1 VIAL, MULTI-DOSE 83703-0569-73 — On market View →
MESNEX mesna 100 mg/mL INJECTION, SOLUTION Bamboo · NDC 83703-0559-01 · 1 VIAL, MULTI-DOSE in 1 BOX (83703-559-01) / 10 mL in 1 VIAL, MULTI-DOSE 83703-0559-01 — On market View →
paclitaxel 100 mg/20mL INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION Bamboo · NDC 83703-0563-10 · 100 VIAL in 1 CARTON (83703-563-10) / 20 mL in 1 VIAL 83703-0563-10 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 10 ug/mL INJECTION, SUSPENSION Bamboo · NDC 83703-0086-02 · 1 mL in 1 SYRINGE (83703-086-02) 83703-0086-02 — On market View →
RECOMBIVAX HB Hepatitis B Vaccine (Recombinant) 5 ug/.5mL INJECTION, SUSPENSION Bamboo · NDC 83703-0085-02 · .5 mL in 1 SYRINGE (83703-085-02) 83703-0085-02 — On market View →
Rituximab-abbs 10 mg/mL INJECTION, SOLUTION, CONCENTRATE Bamboo · NDC 83703-0582-73 · 273 VIAL in 1 CARTON (83703-582-73) / 10 mL in 1 VIAL 83703-0582-73 — On market View →
Rituximab-abbs 10 mg/mL INJECTION, SOLUTION, CONCENTRATE Bamboo · NDC 83703-0581-84 · 84 VIAL in 1 CARTON (83703-581-84) / 50 mL in 1 VIAL 83703-0581-84 — On market View →
rituximab-arrx 10 mg/mL INJECTION, SOLUTION Bamboo · NDC 83703-0576-48 · 48 VIAL in 1 CARTON (83703-576-48) / 50 mL in 1 VIAL 83703-0576-48 — On market View →
rituximab-arrx 10 mg/mL INJECTION, SOLUTION Bamboo · NDC 83703-0573-48 · 48 VIAL in 1 CARTON (83703-573-48) / 50 mL in 1 VIAL 83703-0573-48 — On market View →
rituximab-arrx 10 mg/mL INJECTION, SOLUTION Bamboo · NDC 83703-0574-80 · 80 VIAL in 1 CARTON (83703-574-80) / 10 mL in 1 VIAL 83703-0574-80 — On market View →
rituximab-arrx 10 mg/mL INJECTION, SOLUTION Bamboo · NDC 83703-0575-80 · 80 VIAL in 1 CARTON (83703-575-80) / 10 mL in 1 VIAL 83703-0575-80 — On market View →
temozolomide 2.5 mg/mL INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION Bamboo · NDC 83703-0577-01 · 35 VIAL in 1 CARTON (83703-577-01) / 40 mL in 1 VIAL 83703-0577-01 — On market View →
tisotumab vedotin 1 mg/mg INJECTION, POWDER, FOR SOLUTION Bamboo · NDC 83703-0578-54 · 54 VIAL in 1 CARTON (83703-578-54) / 40 mg in 1 VIAL 83703-0578-54 — On market View →
Where does this data come from?
NDC package records, ingredients, strengths and forms come from the openFDA NDC Directory, grouped by the 5-digit labeler code; pricing is CMS NADAC. This is a factual data directory, not a manufacturer marketing page.